Menu Back toSession 6: Future Developments and Projects on Clinical Trial Regulations

Clinical Trial Regulation Conference

Join experts from regulatory, ethics bodies, sponsors and patients to discuss the launch of the Clinical Trial Regulation and new trends of Clinical Trials in Europe.


Session 6: Future Developments and Projects on Clinical Trial Regulations

Session Chair(s)

Nick  Sykes, MS

Nick Sykes, MS

  • Senior Director, Global Regulatory Affairs
  • Pfizer, Inc., United Kingdom
The conduct and management of clinical trials continues to evolve. A number of initiatives and programmes have been established to ensure the regulatory oversight of clinical trials is aligned with the way clinical trials are being conducted and planned. This session will explore some of the ongoing work from some of the initiatives and will discuss how they will help ensure clinical research can continue to be conducted effectively and efficiently.

Speaker(s)

Solange  Corriol-Rohou, DrMed, MD, PhD

Developments in ICH

Solange Corriol-Rohou, DrMed, MD, PhD

  • Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
  • AstraZeneca , France
Magda  Chlebus, MA

What has been done in IMI Project (to support Clinical Development)

Magda Chlebus, MA

  • Executive Director, Science Policy & Regulatory Affairs
  • EFPIA, Belgium
Alison  Bond, PhD

TransCelerate Initiatives to Modernise Clinical Development

Alison Bond, PhD

  • Director, Global Regulatory and R&D Policy
  • AMGEN, United Kingdom

Contact us

Registration Questions?

Send Email
+41 61 225 51 51